Home Tags Pharmaceutical Industry

Tag: Pharmaceutical Industry

The Trump administration’s top health official isn’t counting on pharma to bring down drug prices

The Trump administration has been vocal about lowering drug prices in the US, coming to a head in July when President Donald Trump singled out pharma giant Pfizer for its price increases.

A startup with ties to Bayer has inked a $122 million deal to make lab-grown marijuana — and it’s eyeing the pharma industry

Boston-based startup Ginkgo Bioworks will use Cronos' labs to produce synthetic marijuana compounds, many of which "have the potential to be valuable in a range of pharmaceutical applications."

Stanford researchers are figuring out how ketamine fights depression — and why the drug has been called ‘the most important discovery in h...

A new Stanford study is the first to illuminate how ketamine works in the brain to alleviate depression. The research suggests that the drug engages the opioid system — the same one that's activated by opioid painkillers — in addition to affecting the glutamate system.

A Silicon Valley pharmacy delivery startup just became the first to offer an at-home lab test for a popular HIV-preventing medication

Nurx, a Silicon Valley prescription drug delivery startup that once solely dispensed birth control, is launching a new service that allows patients who want HIV-prevention drug Truvada to do all the required testing at home.

The drug maker behind the first FDA-approved medication derived from marijuana has revealed how much it’ll cost

On a call with investors this week, GW Pharmaceuticals revealed the price of Epidiolex, its newly-approved, marijuana-based drug for rare forms of epilepsy.

DNA-testing companies like 23andMe sell your genetic data to drugmakers and other Silicon Valley startups

DNA-testing company 23andMe made headlines last week when it announced that it would share consumers' anonymized genetic data with pharmaceutical giant GlaxoSmithKline. Companies like 23andMe frequently share your DNA data with "third parties."
23andMe CEO Anne Wojcicki explained why the company is working with GSK to develop drugs.

Here’s the email 23andMe sent its customers after GSK bought a $300 million stake in the company

"23andMe has created a research platform to enable interested customers to participate in research - to not wait for solutions to appear, but for people to come together and make discoveries happen," 23andMe's CEO wrote. "By working with GSK, we believe we will accelerate the development of breakthroughs."

DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here’s how to delete your data if that freaks you out.

Genetics-testing companies like Ancestry and 23andMe can — and frequently do — sell your data to drugmakers. A $300 million deal between 23andMe and the pharmaceutical giant GlaxoSmithKline is the latest example. If that has you thinking about how these companies use your data, here's how to delete it.

Why pharma giant GSK just made a $300 million bet on 23andMe’s approach to finding new medicines

The consumer genetics company 23andMe is teaming up with the UK drug giant GlaxoSmithKline to develop new drugs. As part of the four-year collaboration, GSK is committing $300 million to 23andMe and is working on an experimental drug to treat Parkinson's disease.
Instead of turning to surgery, drugmakers are hoping to treat diseases like uterine fibroids and endometriosis with new medications.

A new treatment for a condition that can feel like tiny people skating on razor blades in your stomach and affects an estimated 200 million women just...

The FDA just approved elagolix, a new treatment for women living with endometriosis. Endometriosis, a condition that affects millions of women, occurs when tissue from the uterus grows outside of it, leading to cysts, heavy bleeding, and scarring.